Menu Navigation
  • About Us
    • The Centre
    • Our Team
    • Board of Directors
    • EFW Radiology
  • Prostate Cancer
    • Newly Diagnosed
    • About the Prostate
    • Risk Factors & Symptoms
    • Diagnosing
  • Volunteer Recruitment
  • Our Programs
    • Patient Services
    • Clinical Studies
    • Our Research
    • The MAN VAN™
    • Men’s Health
  • News & Events
    • Blog
    • Newsletters
    • Publications
    • Annual Reports
    • PSA Stance
  • Contact Us
  • Support Us
    • Women for Men’s Health
    • #Love&Hope Initiative
Prostate Cancer Centre - Calgary
  • Get Checked
  • Donate
Prostate Cancer Centre - Calgary
  • About Us
    • The Centre
    • Our Team
    • Board of Directors
    • EFW Radiology
  • Prostate Cancer
    • Newly Diagnosed
    • About the Prostate
    • Risk Factors & Symptoms
    • Diagnosing
  • Volunteer Recruitment
  • Our Programs
    • Patient Services
    • Clinical Studies
    • Our Research
    • The MAN VAN™
    • Men’s Health
  • News & Events
    • Blog
    • Newsletters
    • Publications
    • Annual Reports
    • PSA Stance
  • Contact Us
  • Support Us
    • Women for Men’s Health
    • #Love&Hope Initiative

News & Events

Baseline Serum Testosterone in Men Treated with Androgen Deprivation Therapy and Radiotherapy for Localized Prostate Cancer

Posted Oct. 22nd, 2014.

It is believed that men diagnosed with prostate cancer and a low baseline serum testosterone (BST) may have more aggressive disease and it is frequently recommended they forego testosterone replacement therapy. We used two large phase III trials involving androgen deprivation therapy (ADT)…

Read more »

Impact of ultrahigh baseline PSA levels on biochemical and clinical outcomes in two Radiation Therapy Oncology Group prostate clinical trials

Posted Oct. 22nd, 2014.

To assess ultra-high (UH; PSA ≥  50 ng/ml) patient outcomes compared to other high risk patients and to identify outcome predictors.

Furthering the prostate cancer screening debate (prostate cancer specific mortality and associated risks)

Posted Oct. 22nd, 2014.

Screening for prostate cancer remains a contentious issue. As with other cancer screening programs, a key feature of the debate is verification of cancer-specific mortality reductions. Unfortunately the present evidence, two systematic reviews and six randomized controlled trials, have reported conflicting results. Furthermore, half of…

Read more »

Contemporary Analysis of Erectile, Voiding, and Oncologic Outcomes Following Primary Targeted Cryoablation of the Prostate for Clinically Localized Prostate Cancer

Posted Oct. 22nd, 2014.

To evaluate erectile function (EF) and voiding function following primary targeted cryoablation of the prostate (TCAP) for clinically localized prostate cancer (CaP) in a contemporary cohort.

Interrogation of ERG gene rearrangements in prostate cancer identifies a prognostic 10-gene signature with relevant implication to patients’ clinical outcome

Posted Oct. 7th, 2014.

ETS (E26) fusions have been proposed to constitute a unique molecular subtype of prostate cancer (PCA), as evidenced by both their mutual exclusivity with other proposed PCA subtypes and the fundamentally different chromatin biology conferred by ETS-positivity [1–6]. These findings…

Read more »

Event funds benefit Prostate Cancer Centre

Posted Sep. 8th, 2014.

Remington_2014

  • ←
  • 1
  • 2
  • 3
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 31
  • 32
  • 33
  • →

Recent Posts

  • International Women’s Day 2022 – Celebrating the achievements of Linda MacNaughton, Director of Resource & Community Development
  • Dr. Shelley Spaner: Breaking the Barrier for Men’s Health
  • Jack Paul’s Prostate Cancer Journey
  • Duane’s Christmas Miracle
  • Announcement from Keith Steeves, Chairman of the Board of Directors of the Prostate Cancer Centre

Categories

  • Articles
  • Combines for Cures
  • Events
  • Keep It In Calgary
  • MAN VAN
  • Men's Health
  • News
  • PCC
  • PCC Research
  • Press Releases
  • Research Articles
  • Resources
  • Testimonials
  • Uncategorized
  • Video Resources
  • Women For Men's Health

Archives

  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • January 2021
  • November 2020
  • October 2020
  • September 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • October 2019
  • June 2019
  • April 2019
  • March 2019
  • September 2018
  • August 2018
  • June 2018
  • May 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • October 2017
  • September 2017
  • August 2017
  • June 2017
  • May 2017
  • February 2017
  • January 2017
  • December 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • February 2016
  • January 2016
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013

Men over 40
get checked.

In Canada, one in nine men will be diagnosed with prostate cancer in their lifetime. When detected early, prostate cancer is one of the most successfully treated types of cancer.

The staff and volunteers at Calgary Prostate Cancer Centre are dedicated to educating men about the importance of early detection.

Calgary Prostate Cancer Centre

Southern Alberta Institute of Urology
Rockyview General Hospital
6500-7007 14 Street SW
Calgary, AB T2V 1P9
(403) 943-8888

Charitable #: 893376327RR0001

Support Us
Prostate Cancer Centre - Calgary

Copyright 2016 Prostate Cancer Centre Calgary. All Rights Reserved

  • Privacy Policy
  • Site Map
  • Career Opportunities